1. 2020
  2. Impact of nitisinone treatment and discontinuation on the metabolome of wildtype and hereditary tyrosinemia type 1 mice

    Colemonts-Vroninks, H., Norman, B., Davison, A., Neuckermans, J., Marcélis, L., Mortier, A., De Bundel, D., Ranganath, L., Martens, G., Vanhaecke, T., Gallagher, J. & De Kock, J., 17 Apr 2020, p. FRI284.

    Research output: Unpublished contribution to conferencePoster

  3. The Impact of Cell-Expansion and Inflammation on The Immune-Biology of Human Adipose Tissue-Derived Mesenchymal Stromal Cells.

    Buyl, K., Merimi, M., Rodrigues, R., Agha, D. M., Melki, R., Vanhaecke, T., Bron, D., Lewalle, P., Meuleman, N., Fahmi, A. H., Rogiers, V., Lagneaux, L. & De Kock, J., 3 Apr 2020, In : Journal of Clinical Medicine. E696, 9, 9(3).

    Research output: Contribution to journalArticle

  4. Impact of the revised European Tobacco Product Directive onn the quality of e-cigarette refill liquids in Belgium

    Barhdadi, S., Moens, G., Canfyn, M., Desmedt, B., Vanhee, C., Courselle, P., Rogiers, V., Vanhaecke, T. & Deconinck, E., 29 Jan 2020, In : Nicotine and Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco.

    Research output: Contribution to journalArticle

  5. Facilitating Data Curation: a Solution Developed in the Toxicology Domain

    Debruyne, C., Riggio, J., Gustafson, E., O'Sullivan, D., Vinken, M., Vanhaecke, T. & De Troyer, O., 2020, 14th IEEE International Conference on Semantic Computing (ICSC 2020). IEEE, p. 315-320

    Research output: Chapter in Book/Report/Conference proceedingConference paper

  6. Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury

    Gijbels, E., Vilas-Boas, V., Annaert, P., Vanhaecke, T., Devisscher, L. & Vinken, M., 2020, (Accepted/In press) In : Archives of Toxicology.

    Research output: Contribution to journalArticle

  7. The SCCS guidance on the safety assessment of nanomaterials in cosmetics.

    Vanhaecke, T. & Rogiers, V., 2020, In : Regulatory Toxicology and Pharmacology. 112, 2 p., 104611.

    Research output: Contribution to journalArticle

  8. The way forward for assessing the human health safety of cosmetics in the EU workshop proceedings

    Rogiers, V., Benfenati, E., Bernauer, U., Bodin, L., Carmichael, P., Chaudhry, Q., Coenraads, P. J., Cronin, M. T. D., Dent, M., Dusinska, M., Ellison, C., Ezendam, J., Gaffet, E., Galli, C. L., Goebel, C., Granum, B., Hollnagel, H. M., Kern, P. S., Kosemund-Meynen, K., Ouédrago, G. & 6 others, Panteri, E., Rouselle, C., Stepnik, M., Vanhaecke, T., von Goetz, N. & Worth, A., 2020, In : Toxicology. 436, 14 p., 152421.

    Research output: Contribution to journalArticle

  9. 2019
  10. Anti-NASH Drug Development Hitches a Lift on PPAR Agonism

    Boeckmans, J., Natale, A., Rombaut, M., Buyl, K., Rogiers, V., De Kock, J., Vanhaecke, T. & Rodrigues, R., 21 Dec 2019, In : Cells. 9, 1, p. 1-20 20 p., 37.

    Research output: Contribution to journalArticle

Previous 1 2 3 4 5 6 7 8 ...34 Next

ID: 46467